I just logged in and saw a 2,500,000 share transaction reported today
about time we saw a serious buyer enter at these oversold levels
the negative investor response to the bio sector as a whole after Opthea failed results was way silly to tar every bio in trials with the same brush off
Recce327 entering phase 111 trial on DFUlcer infections is very comfortable of great results given already large data evidence of terrific efficacy from the ABSSSI trials and TGA accessed patients to the drug
wish i had bought 2.5 m here
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.020(6.56%) |
Mkt cap ! $93.72M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 33.0¢ | 30.0¢ | $75.15K | 239.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10934 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |